Clinical Trials Browser

Phase 1/2 × SCLC, Extensive Stage × Drug Therapy × Clear all

NCT06477523 2024-06-27

Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC

Phase 1/2 Recruiting

SCLC, Extensive Stage